T helper (Th)17 immune response participates in allergic lung inflammation and asthma is reduced in the absence of interleukin (IL)-17 in mice. Since IL-17A and IL-17F are induced and bind the shared receptor IL-17RA, we asked whether both IL-17A and IL-17F contribute to house dust mite (HDM) induced asthma. We report that allergic lung inflammation is attenuated in absence of either IL-17A or IL-17F with reduced airway hyperreactivity, eosinophilic inflammation, goblet cell hyperplasia, cytokine and chemokine production as found in absence of IL-17RA. Furthermore, specific antibody neutralization of either IL-17A or IL-17F given during the sensitization phase attenuated allergic lung inflammation and airway hyperreactivity. In vitro activation by HDM of primary dendritic cells revealed a comparable induction of CXCL1 and IL-6 expression and the response to IL-17A and IL-17F relied on IL-17RA signaling via the adaptor protein act1 in fibroblasts. Therefore, HDM-induced allergic respiratory response depends on IL-17RA via act1 signaling and inactivation of either IL-17A or IL-17F is sufficient to attenuate allergic asthma in mice.
Skip Nav Destination
Article navigation
October 2017
-
Cover Image
Cover Image
In this issue of Clinical Science, Thompson et al (pages 2489-2501) describe their research on the capacity of protein tyrosine phosphatase 1B inhibitor to reverse atherosclerotic plaque formation in a mouse model. The cover image shows aortic root sections of mice fed on a high-fat-diet that are stained with Oil Red - a method the authors used to quantify plaque formation in this study.
Research Article|
October 13 2017
Neutralization of either IL-17A or IL-17F is sufficient to inhibit house dust mite induced allergic asthma in mice
Pauline Chenuet;
Pauline Chenuet
1Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, 3B, F-45071 Orleans-Cedex2, France
Search for other works by this author on:
Louis Fauconnier;
Louis Fauconnier
2Artimmune SAS, 13 Avenue Buffon, Orléans 45100, France
Search for other works by this author on:
Fahima Madouri;
Fahima Madouri
1Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, 3B, F-45071 Orleans-Cedex2, France
Search for other works by this author on:
Tiffany Marchiol;
Tiffany Marchiol
2Artimmune SAS, 13 Avenue Buffon, Orléans 45100, France
Search for other works by this author on:
Nathalie Rouxel;
Nathalie Rouxel
2Artimmune SAS, 13 Avenue Buffon, Orléans 45100, France
Search for other works by this author on:
Aurélie Ledru;
Aurélie Ledru
2Artimmune SAS, 13 Avenue Buffon, Orléans 45100, France
Search for other works by this author on:
Pascal Mauny;
Pascal Mauny
1Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, 3B, F-45071 Orleans-Cedex2, France
Search for other works by this author on:
Rachel Lory;
Rachel Lory
1Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, 3B, F-45071 Orleans-Cedex2, France
Search for other works by this author on:
Catherine Uttenhove;
Catherine Uttenhove
3Ludwig Cancer Research Ltd, Brussels Branch, Avenue Hippocrate 74, UCL, 7459 B-1200 Brussels, Belgium
Search for other works by this author on:
Jacques van Snick;
Jacques van Snick
3Ludwig Cancer Research Ltd, Brussels Branch, Avenue Hippocrate 74, UCL, 7459 B-1200 Brussels, Belgium
Search for other works by this author on:
Yoichiro Iwakura;
Yoichiro Iwakura
5Research Institute for Biomedical Sciences, Tokyo University, Chiba 278-0022, Japan
Search for other works by this author on:
Franco di Padova;
Franco di Padova
4Novartis Institutes for BioMedical Research (NIBR) WSJ 386 10-48-62, Basel, Switzerland
Search for other works by this author on:
Valérie Quesniaux;
Valérie Quesniaux
1Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, 3B, F-45071 Orleans-Cedex2, France
Search for other works by this author on:
Dieudonnée Togbe;
2Artimmune SAS, 13 Avenue Buffon, Orléans 45100, France
Correspondence: Dieudonnée Togbe ([email protected] or [email protected]) or Bernhard Ryffel ([email protected])
Search for other works by this author on:
Bernhard Ryffel
1Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orleans, 3B, F-45071 Orleans-Cedex2, France
6IDM, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa
Correspondence: Dieudonnée Togbe ([email protected] or [email protected]) or Bernhard Ryffel ([email protected])
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
May 10 2017
Revision Received:
August 24 2017
Accepted:
August 29 2017
Online ISSN: 1470-8736
Print ISSN: 0143-5221
© 2017 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society
2017
Clin Sci (Lond) (2017) 131 (20): 2533–2548.
Article history
Received:
May 10 2017
Revision Received:
August 24 2017
Accepted:
August 29 2017
Citation
Pauline Chenuet, Louis Fauconnier, Fahima Madouri, Tiffany Marchiol, Nathalie Rouxel, Aurélie Ledru, Pascal Mauny, Rachel Lory, Catherine Uttenhove, Jacques van Snick, Yoichiro Iwakura, Franco di Padova, Valérie Quesniaux, Dieudonnée Togbe, Bernhard Ryffel; Neutralization of either IL-17A or IL-17F is sufficient to inhibit house dust mite induced allergic asthma in mice. Clin Sci (Lond) 1 October 2017; 131 (20): 2533–2548. doi: https://doi.org/10.1042/CS20171034
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.